The $5.04M insider buy cluster at $18/share is a strong bullish signal, especially given the simultaneous derivative conversions by the same insiders. Traders should watch for a near-term catalyst (e.g., clinical data readout, partnership, or financing) that may have prompted this coordinated confidence. The stock's recent insider activity (30d) shows only $2.5M in prior buys, making this cluster a significant escalation.
Price Chart
Executive Summary
Two major insiders at Latigo Biotherapeutics (LTGO) — a director/10% owner and a 10% owner entity — collectively purchased $5.04M of stock on the open market at $18/share on August 10, 2026. This is a strong cluster buy signal, representing ~0.46% of the $1.1B market cap, and is amplified by the simultaneous conversion of large derivative positions by the same insiders, suggesting a coordinated vote of confidence ahead of a potential catalyst.
Key Financial Metrics
Key Facts
- Director James B. Tananbaum purchased 140,000 shares at $18.00 for $2.52M on 2026-08-10.
- Foresite Capital Management V, LLC purchased 140,000 shares at $18.00 for $2.52M on 2026-08-10.
- Total open-market purchases: $5.04M, representing ~0.46% of LTGO's $1.1B market cap.
- Both insiders also converted millions of shares of derivative securities (non-cash) on the same date, indicating a coordinated event.
- The cluster is a C-suite-level signal (director + 10% owner) and is amplified by the cross-filing context of derivative conversions.
Financial Impact
Two insiders purchased $5.04M of stock at $18/share, representing ~0.46% of market cap.
Risk Factors
- The derivative conversions add ~17M shares of potential dilution, which could offset some of the bullish signal.
- Biotech stocks are binary — a negative catalyst could erase gains despite insider buying.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LTGO-1786442871959 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $23.04 $23.73 | ▲ +2.99% | ▲ +3.54% | $15.21 (−33.98%) |
Aug 12, 2026 10w ago | 3 | $19.38 $20.06 | ▲ +3.54% | ▲ +2.84% | $15.21 (−21.50%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | 8-K | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 7, 2026 11w ago | EFFECT | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers